科思创，又一高端产品投产

Core Viewpoint - Covestro has officially launched its medical-grade thermoplastic polyurethane (TPU) Desmopan® Rx series at its Changhua site in Taiwan, marking it as the second facility globally to receive medical-grade TPU production certification, addressing the growing demand for high-performance medical materials in the Asia-Pacific market [1][2]. Group 1: Product and Production Details - The new production line adheres to Good Manufacturing Practice (GMP) standards, ensuring products are free from plasticizers and have low extractables, supporting various sterilization methods, and have passed ISO 10993 and national biocompatibility certifications [2]. - Desmopan® Rx materials are specifically designed for medical device components, including thin-walled flexible tubes, catheters, connectors, component housings, endoscopes, healthcare devices, and wearable products, with applications in surgical procedures, dialysis, drug delivery, and wound care [2]. - The series is compatible with melt-blown processes, allowing the production of medical-grade non-woven fabrics for surgical drapes, wound dressings, and surgical gowns, compliant with medical waste disposal regulations [2]. Group 2: Strategic Developments - In September of the previous year, Covestro announced the establishment of a new TPU Asia-Pacific application development center in Guangzhou, aimed at enhancing proximity to the TPU industry cluster in China and the Asia-Pacific region, particularly in consumer electronics and specialty extrusion [3]. - Covestro has initiated the construction of its largest TPU production base in Zhuhai, expected to reach an annual capacity of nearly 120,000 tons by 2033, creating a collaborative synergy among the Guangzhou application development center, Changhua R&D center, and Zhuhai production base [3].